<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Hematol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann. Hematol</journal-id>
      <journal-title-group>
        <journal-title>Annals of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0939-5555</issn>
      <issn pub-type="epub">1432-0584</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21976107</article-id>
      <article-id pub-id-type="pmc">3345120</article-id>
      <article-id pub-id-type="publisher-id">1344</article-id>
      <article-id pub-id-type="doi">10.1007/s00277-011-1344-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Successful transfusion care for a patient with the Rhesus -D- phenotype and antibodies against Rh17 and two additional alloantibodies</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>De Vooght</surname>
            <given-names>Karen M. K.</given-names>
          </name>
          <address>
            <phone>+31-88-7558748</phone>
            <fax>+31-88-7555418</fax>
            <email>k.devooght@umcutrecht.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Demir</surname>
            <given-names>Ay&#x15F;e Y.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Folman</surname>
            <given-names>Claudia C.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schutgens</surname>
            <given-names>Roger E. G.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van Solinge</surname>
            <given-names>Wouter W.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kemperman</surname>
            <given-names>Hans</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Postbus 85500, 3508 GA Utrecht, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Department of Clinical Chemistry and Haematology, Meander Medical Center, Amersfoort, The Netherlands </aff>
        <aff id="Aff3"><label>3</label>Sanquin Diagnostic Services, Amsterdam, The Netherlands </aff>
        <aff id="Aff4"><label>4</label>Department of Haematology/Van Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>10</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>6</day>
        <month>10</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2012</year>
      </pub-date>
      <volume>91</volume>
      <issue>6</issue>
      <fpage>963</fpage>
      <lpage>964</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>6</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>9</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2011</copyright-statement>
      </permissions>
      <kwd-group kwd-group-type="journal subjects">
        <kwd>Medicine &amp; Public Health</kwd>
        <kwd>Hematology</kwd>
        <kwd>Oncology</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2012</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>In transfusion medicine, it can be a challenge to obtain compatible blood for patients who have clinically important alloantibodies to high-prevalence antigens. We describe a case which examples the decision process for autologous blood deposition in the Dutch health care system.</p>
    <p>In September 2006, a 56-year-old man was admitted to the emergency room after a serious accident. Coagulation and hematology parameters were in normal range except for a low hemoglobin of 7.9&#xA0;g/dL. His blood group was determined as O, Rhesus D-positive and antibody screening (DiaMed) was negative. Transfusion anamnesis was also negative. Two units of packed erythrocytes were administrated. Eight days later hemoglobin had dropped to 7.1&#xA0;g/dL. Upon a negative antibody screening, 2&#xA0;units of erythrocytes were transfused. After 20&#xA0;days, the patient had to undergo surgery. Now, antibody screening and identification, using standard and papain enzyme-treated panels (DiaMed), demonstrated strong positive reactions with all cells. These results were suggestive for the presence of an alloantibody against a high-prevalence antigen. Further serologic and genetic analysis revealed that C/c and E/e antigens were completely absent on the surface of the patient's erythrocytes, indicating the presence of the rare -D-/-D- phenotype [<xref ref-type="bibr" rid="CR1">1</xref>]. Adsorption and elution studies revealed the presence of anti-C, -E, -e, -Ce, and -cE alloantibodies and antibodies against the high-prevalence antigens of the RhCcEe polypeptide (anti-Rh17 antibodies) [<xref ref-type="bibr" rid="CR2">2</xref>]. Furthermore, we identified alloantibodies against Jk<sup>a</sup> and Le<sup>a</sup>.</p>
    <p>Hemolytic transfusion reactions due to anti-Le<sup>a</sup> are rare [<xref ref-type="bibr" rid="CR3">3</xref>]. Anti-Rh17 [<xref ref-type="bibr" rid="CR4">4</xref>] and anti-Jk<sup>a</sup> antibodies, however, can lead to massive hemolysis. Therefore, only erythrocytes of donors with the -D- phenotype, negative for Jk<sup>a</sup>, could be selected for transfusion. The -D- haplotype is rare, ranging in frequency from 0.0005 in Sweden [<xref ref-type="bibr" rid="CR5">5</xref>] to 0.0032 in Japan [<xref ref-type="bibr" rid="CR6">6</xref>], and homozygosity for RHCE-D-CE hybrid genes appears to account for several examples of -D- [<xref ref-type="bibr" rid="CR1">1</xref>]. Worldwide, only two suitable donors were registered. Since the risk of substantial blood loss was low, the patient underwent surgery in the absence of compatible donor erythrocytes. The patient was encouraged to donate autologous blood to be stored at the Sanquin Bank of Frozen Blood (SBFB). In November 2009, the patient was scheduled for coronary artery bypass graft surgery. It was estimated that, by optimal use of intraoperative cell salvage, the patient would maximally need 1&#xA0;unit of blood. Five weeks before surgery, the patient's hemoglobin was 15.1&#xA0;g/dL, allowing preoperative donation of 2&#xA0;units of fresh blood. In case of need, frozen units of the SBFB could also be thawed. During surgery in December 2009, 1&#xA0;unit of fresh autologous blood and 400&#xA0;mL of cell salvage blood was transfused to the patient. Postoperatively the patient's hemoglobin level was 11.1&#xA0;g/dL. He was discharged from the hospital 9&#xA0;days later.</p>
    <p>To date the clinical relevance of the -D- phenotype has been predominantly described in pregnant women, causing mild to fatal hemolytic disease of the newborn [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR7">7</xref>&#x2013;<xref ref-type="bibr" rid="CR10">10</xref>]. We describe the successful treatment of a patient with recurrent need of transfusions despite the presence of antibodies against the high-prevalence antigens of the RhCcEe polypeptide combined with anti-Jk<sup>a</sup>.</p>
  </body>
  <back>
    <ack>
      <p>The authors would like to thank Peter Ligthart (Department of Immunohaematology Diagnostic Services, Sanquin Blood Supply, Amsterdam, The Netherlands) for his consultancy.</p>
      <sec id="d29e298">
        <title>Conflict of interest</title>
        <p>The authors declare to hold no conflict of interest with the publication of the results included in this manuscript.</p>
      </sec>
      <sec id="d29e303">
        <title>Open Access</title>
        <p>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Avent</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Reid</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>The Rh blood group system: a review</article-title>
          <source>Blood</source>
          <year>2000</year>
          <volume>95</volume>
          <fpage>375</fpage>
          <lpage>387</lpage>
          <pub-id pub-id-type="pmid">10627438</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flegel</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>FF</given-names>
            </name>
          </person-group>
          <article-title>Molecular genetics of RH</article-title>
          <source>Vox Sang</source>
          <year>2000</year>
          <volume>78</volume>
          <issue>S2</issue>
          <fpage>109</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="pmid">10938938</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henry</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Oriol</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Samuelsson</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Lewis histo-blood group system and associated secretory phenotypes</article-title>
          <source>Vox Sang</source>
          <year>1995</year>
          <volume>69</volume>
          <issue>3</issue>
          <fpage>166</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1423-0410.1995.tb02591.x</pub-id>
          <pub-id pub-id-type="pmid">8578728</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Shim</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
          <article-title>A case of fatal hemolytic disease of the newborn associated with -D-/-D- phenotype</article-title>
          <source>Am J Perinatol</source>
          <year>1997</year>
          <volume>14</volume>
          <fpage>495</fpage>
          <lpage>497</lpage>
          <pub-id pub-id-type="doi">10.1055/s-2007-994188</pub-id>
          <pub-id pub-id-type="pmid">9376014</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rasmuson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Heiken</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Frequency of occurrence of the human Rh complexes D(C)(e), d(c)(e), D&#x2014; and&#x2014;</article-title>
          <source>Nature</source>
          <year>1966</year>
          <volume>212</volume>
          <issue>5068</issue>
          <fpage>1377</fpage>
          <lpage>1379</lpage>
          <pub-id pub-id-type="doi">10.1038/2121377a0</pub-id>
          <pub-id pub-id-type="pmid">4961455</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okubo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tomita</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nagao</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Mass screening donors for -D- and Jk (a-b-) using the Groupamatic-360</article-title>
          <source>Transfusion</source>
          <year>1983</year>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>362</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1537-2995.1983.23483276884.x</pub-id>
          <pub-id pub-id-type="pmid">6410555</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deitenbeck</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tutschek</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Crombach</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stannigel</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Successful management of pregnancy and hemolytic disease of the newborn due to anti-Hr<sub>o</sub> in a woman of the D&#x2014;phenotype</article-title>
          <source>Transfusion</source>
          <year>1999</year>
          <volume>39</volume>
          <fpage>1151</fpage>
          <lpage>1152</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1537-2995.1999.t01-1-39101150.x</pub-id>
          <pub-id pub-id-type="pmid">10532613</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brumit</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Carnahan</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Stubbs</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Moderate hemolytic disease of the newborn (HDN) due to anti-Rh17 produced by a black female with an e variant phenotype</article-title>
          <source>Immunohematology</source>
          <year>2002</year>
          <volume>18</volume>
          <fpage>40</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">15373563</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aref</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Boctor</surname>
              <given-names>FN</given-names>
            </name>
            <name>
              <surname>Pande</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Successful perinatal management of hydrops fetalis due to hemolytic disease associated with D&#x2014;maternal phenotype</article-title>
          <source>J Perinatol</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>667</fpage>
          <lpage>668</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.jp.7210775</pub-id>
          <pub-id pub-id-type="pmid">12478452</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirose</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakanishi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kaku</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fetal hemolytic disease due to anti-Rh17 alloimmunization</article-title>
          <source>Fetal Diagn Ther</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>182</fpage>
          <lpage>186</lpage>
          <pub-id pub-id-type="doi">10.1159/000075147</pub-id>
          <pub-id pub-id-type="pmid">14764967</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
